A medication price is only one part of the decision at Third Avenue. Its public pages advertise compounded semaglutide and tirzepatide, an online assessment, pharmacy coordination and ongoing support. They also describe a separate membership that becomes an annual charge after a short trial. For someone comparing programs, the useful questions are therefore broader than whether the advertised medicine price looks attractive: what will be charged, who will provide medical care, and what happens when an order or clinical need changes?
Public documentation consulted October 19, 2026 provides concrete answers to some of those questions and conflicting answers to others. This review examines the published offer rather than reporting personal treatment experience. In particular, monthly language appears alongside a 25-day billing statement, shipping descriptions vary, and two pages give different windows for reporting damaged products. Those differences deserve clarification before checkout; they do not establish that treatment is unavailable or that every patient will encounter a problem.
At a glance
- Who provides care?
- The terms identify Third Ave LLC as the platform operator and MDI Medical Group PC and applicable affiliated professional entities as the clinical group.Sources: [10]
- What is advertised?
- Compounded semaglutide and tirzepatide injections; the exact formulation and pharmacy depend on clinical review, location and availability.
- What are the separate charges?
- Medication pages display $49/month for semaglutide and $68/month for tirzepatide, plus membership at $199/year after a seven-day trial. Alternative prices and billing language need clarification.
- Where is access offered?
- The platform advertises telehealth access for eligible patients physically in all 50 states, while warning that individual treatments, providers and pharmacies vary by location.Sources: [5]
Who would actually be responsible for my care?
The website is operated by Third Ave LLC, a Delaware limited liability company doing business as Third Avenue. Its terms explicitly separate that company from the practice of medicine and from pharmacy services. The clinical organization named in those terms is MDI Medical Group PC, together with applicable affiliated professional entities. The platform’s description of handling consultation, prescribing and fulfillment in one place is therefore a description of coordination; it should not be read as proof that the same organization performs every function.
That distinction gives a prospective patient several useful questions. Which medical entity and individual clinician would handle the evaluation? Which organization would answer a medical question after enrollment? Who would resolve a billing dispute or arrange a pharmacy investigation? A familiar brand can make a process easier to navigate, but the brand name alone does not answer those responsibility questions. Our guide to the information a program should explain before enrollment provides a wider framework for organizing the answers.
The privacy documentation says clinical intake information, medical history, diagnoses, treatment decisions and medical records are collected and maintained by the independent medical group and licensed healthcare providers. If you expect to share information with an existing clinician or later change programs, ask how records can be requested and where the relevant clinical record will be held. The consulted passages identify responsibility for maintaining records; they do not establish a specific transfer turnaround or verify any individual professional’s credentials.
What product would I receive, and what remains unspecified?
Third Avenue’s product pages identify compounded semaglutide and compounded tirzepatide, and its program presentation describes prescription injections. The semaglutide page says the exact formulation and dispensing pharmacy depend on clinical review, the patient’s state and current fulfillment availability. That is more specific than an ingredient name alone, but it still leaves details to confirm for a particular order. The consulted documentation does not establish the complete composition, concentration, source manufacturer or documented batch testing for every preparation.
Ask for the actual product description, administration route, dispensing pharmacy and information that will accompany the prescription. Do not assume that a branded medicine studied in a trial, a compounded preparation and a differently formulated product have identical supporting evidence. Third Avenue itself states that compounded medications are not FDA approved and are not reviewed by FDA for safety, effectiveness or quality. That regulatory distinction does not, by itself, prove equivalence or inequivalence to a particular approved product.
FDA recommends that compounded drugs be used when an individual’s medical needs cannot be met by an approved drug. The personal question of whether that situation applies belongs with the treating clinician. A low advertised price, an ingredient shared with a studied medicine or a broad marketing claim cannot settle it. The practical goal of asking about the formulation is to know what is being proposed and which evidence applies, rather than treating the website’s product category as a complete clinical explanation.
Which price and billing calendar would apply to me?
The product pages advertise semaglutide medication at $49 per month and tirzepatide medication at $68 per month, with the same medication price described at any dose. Both are presented separately from Third Avenue Membership, which has a seven-day free trial followed by a $199 annual charge. The trial begins at checkout and applies to membership: the membership explanation says medication is still paid for during that period. A free membership trial therefore does not mean free medicine or a no-charge checkout.
The price displays need reconciliation before they become a usable budget. The semaglutide page also displays $98 per month, while the tirzepatide page also displays $135 per month. The consulted material does not explain all the conditions attached to those alternative amounts. In addition, the enrollment material describes tirzepatide as billed at $68 every 25 days, while other passages describe monthly subscriptions and monthly prices. A 25-day billing interval is not the same as a calendar month, and it does not establish the precise medication quantity supplied.
Request a written explanation of the medication amount charged today, the next medication charge date, the membership trial end date and the annual membership charge. Ask whether the specific checkout uses the 25-day or monthly arrangement and which displayed medication price applies. Third Avenue’s terms describe cash-pay services and say it does not submit claims to commercial insurance or government healthcare programs. They also do not guarantee reimbursement through insurance, an HSA, an FSA or another benefit arrangement. Those payment routes should not be assumed to cover the quoted charges.
| Published item | What it describes | What to confirm |
|---|---|---|
| Semaglutide at $49/month | Advertised medication charge, with a separate $98/month display | Which price applies to the selected order |
| Tirzepatide at $68/month | Advertised medication charge, with a separate $135/month display | Which price applies and whether billing is every 25 days |
| Seven-day membership trial | Trial of membership, beginning at checkout | Exact trial end date and cancellation confirmation |
| $199/year membership | Annual membership charge after the trial | What remains payable if either recurring charge is stopped |
What would the clinical assessment require?
The product page describes an online medical intake covering health history, lifestyle and goals. The program says a licensed clinician considers overall health and metabolic needs rather than relying on BMI alone. That statement is not a promise that someone will qualify, nor does it identify a personal treatment choice. The terms set an age threshold of at least 18, or the higher age of majority where the patient lives. They also allow the provider to require further information before prescribing or continuing treatment.
Depending on the medicine, location and applicable standards, that additional evaluation may involve live audio-video communication, diagnostic testing, an in-person examination or follow-up care. The consulted pages do not establish one required laboratory panel, testing frequency or universally included laboratory cost. Asking whether further evaluation might be needed is different from assuming that every advertised online intake ends in a prescription. Payment and clinical approval are also distinct: the homepage says payment is collected when the order is placed, before clinical review.
The semaglutide page includes a specific warning that the product is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2, and says a doctor evaluates whether its Semaglutide Microdose offering is appropriate. That is a provider-published restriction to discuss with the clinician, not a complete individualized eligibility assessment. Bring questions about your medical history, current treatment and the proposed product to that conversation. The site’s consultation question guide can help organize the discussion without replacing it.
Which pharmacy would dispense it, and when would it arrive?
Third Avenue’s terms assign prescription fulfillment to independent dispensing pharmacies selected according to the prescription, location, availability and other operational or legal considerations. They do not guarantee a specific pharmacy, and the pharmacy used for an order may change. The general access page advertises telehealth availability for eligible patients physically in all 50 states, but expressly warns that particular medicines, programs, clinicians and pharmacies can vary by state. Nationwide platform access is therefore not a guarantee of a particular product or pharmacy in every location.
A pharmacy transfer may be requested where available and legally permitted, according to the terms. However, the same passage warns that price, availability, formulation, shipping and program services may differ, and some products may not be available from another pharmacy. If using a particular pharmacy matters to you, ask about it before ordering. A transfer option should not be interpreted as a promise that another pharmacy will supply the same preparation at the website’s advertised price.
Delivery descriptions also need a precise starting point. The homepage says orders are typically processed within 24–48 hours after prescription approval and that most arrive within three to five business days, depending on location. Other material advertises free overnight shipping on refills, while enrollment material describes free standard shipping. These are different service descriptions, not a uniform arrival guarantee. Ask what applies to the particular shipment and when tracking becomes available. The shipping questions guide explains why approval, processing, dispatch and arrival should be discussed separately.
What happens if I cancel before or after prescribing?
Third Avenue says either recurring charge can be canceled by emailing support@thirdavenue.com. Its membership explanation says cancellation before the seven-day trial ends avoids the annual membership charge. Neither statement establishes that canceling a future renewal reverses every existing medication order, or that an annual membership already collected receives a proportional refund. The order’s clinical and pharmacy-processing stage matters, so a useful cancellation request should identify both the charge to stop and the status of any current order.
The homepage promises a full refund when a provider does not approve treatment and no prescription is issued. Leaving the intake unfinished is treated differently: the refund policy says the request remains pending and the payment remains applied to it. An incomplete questionnaire does not itself count as cancellation, clinical denial or entitlement to an automatic refund. For an initial order or one requiring a new prescription, provider approval and prescription issuance generally make the order final and nonrefundable, subject to the policy’s exceptions, even before pharmacy transmission or shipping.
Refills under an existing prescription have a different boundary. They become final when submitted to or accepted for processing by the dispensing pharmacy. The policy says a renewal charge will be refunded if cancellation occurs after charging but before submission for pharmacy processing. Ordinary prescription-product returns are not accepted after products leave the pharmacy. Qualifying refunds are generally initiated within five to ten business days after the refund determination; a bank or card issuer may need additional time to post the money. Ask for confirmation of the relevant stage rather than relying only on whether a package has shipped.
Who answers questions and handles delivery problems?
The product page says patients can send secure messages at any time and meet with a physician at scheduled follow-ups. The membership description includes a messageable care team, ongoing check-ins, member pricing and other services. Those statements describe ways to seek support, but the consulted material does not establish an immediate clinical response or a fixed follow-up schedule. The contact page lists support@thirdavenue.com, telephone 302-428-9872 and care-team hours of Monday through Friday, 8 a.m. to 8 p.m. Eastern Time.
Ask which contact route handles medical questions, which handles billing, and what response interval the program can actually commit to. If you already use a GLP-1 through another provider, Third Avenue advertises a care-team review of symptoms and response, along with coaching and longer-term planning. That advertised support does not itself establish that an existing prescription will transfer, that the same product will continue or that a particular clinician will be available at a particular time. Those are separate matters for the clinical and administrative teams to clarify.
For shipment problems, the public pages give conflicting notice windows. The homepage says damaged, defective or incorrect orders should be reported promptly and within seven days of delivery. The refund policy instead calls for immediate reporting and, absent extraordinary circumstances, no later than 48 hours after confirmed delivery; it covers missing or potentially compromised products as well. Ask which instructions govern the order and report concerns promptly. This documentary conflict should not be treated as a reason to delay contacting the provider or pharmacy about a product concern.
Which answers would make the offer easier to evaluate?
A useful next step is a concise written explanation of the exact product, the assigned clinical organization, the dispensing pharmacy, the medication billing interval and the separate membership charge. Ask what supplies and delivery are included, what further clinical evaluation may be required, and who will handle follow-up. The semaglutide page says required supplies, delivery and continued clinical oversight are covered, but that does not settle every laboratory or service cost not specified in the consulted passages. Keep the response tied to the particular program being considered.
Then ask the team to reconcile the published differences: the alternative medication prices, 25-day versus monthly billing, shipping descriptions and delivery-problem notice windows. Preserve the checkout terms and any written clarification, along with cancellation and pharmacy contact details. This is preparation for an informed conversation, not a finding that one interpretation of conflicting text must govern every transaction. The comparison worksheet can help record answers consistently across programs, including where a provider has not yet supplied an answer.
Finally, keep service transparency separate from clinical suitability. A company can explain its prices clearly without establishing treatment outcomes, and an appealing delivery promise does not identify the right medicine for an individual. The reviewed documents do not independently verify clinicians, pharmacies, certifications or patient results. They do provide enough concrete material to ask better questions. Whether the proposed care is appropriate, what assessment is needed and how treatment would be monitored require discussion with the treating healthcare professional.
Questions & answers
Is Third Avenue itself my healthcare provider or pharmacy?
Its terms say it is neither. Third Ave LLC operates the platform, while MDI Medical Group PC and applicable affiliated professional entities provide clinical services. Independent dispensing pharmacies handle prescription fulfillment. Ask which clinician and pharmacy will be responsible for the specific order, rather than assuming the brand name identifies every organization involved.
Does the seven-day free trial include free medication?
No. The membership explanation says the trial starts at checkout and medication is still paid for during it. Membership then continues at $199 per year unless canceled before the trial ends. Medication and membership are separate charges, so confirm both the medication renewal date and the membership trial deadline.
Can I budget using only the $49 or $68 monthly advertisement?
Those are advertised medication amounts, with an additional annual membership charge after the trial. The pages also display alternative medication prices, and enrollment material uses a 25-day billing statement alongside monthly descriptions. Obtain the selected price and billing calendar in writing; the consulted material does not resolve every display or establish the supply quantity per order.
Is a refill treated the same as a new prescription for refunds?
No. The refund policy generally makes an initial order or one requiring a new prescription final after provider approval and prescription issuance, subject to exceptions. An existing-prescription refill becomes final at submission to or acceptance for pharmacy processing. The policy provides a refund for a charged renewal canceled before submission for pharmacy processing. Ask which stage the order has reached.
Does nationwide access mean every medicine is available in every state?
No. The access page describes telehealth availability for eligible patients physically in all 50 states but expressly limits particular programs, medicines, providers and pharmacies according to location and other conditions. The exact formulation and pharmacy can also depend on clinical review and fulfillment availability. Confirm the specific offer for the patient’s location before relying on a general access statement.
How quickly will someone answer a message?
The product page permits secure messages at any time, while the contact page publishes weekday care-team hours from 8 a.m. to 8 p.m. Eastern Time. Neither establishes an immediate reply or a guaranteed clinical response interval. Ask about the appropriate route and expected response for medical questions, billing questions and shipment problems before enrolling.
Our assessment
Third Avenue documents a coordinated telehealth offering with named clinical responsibility, compounded GLP-1 products, separate medication and membership charges, and several practical contact and fulfillment details. Those specifics make the offer possible to examine, but the public differences in price displays, billing intervals, shipping and product-problem deadlines prevent a fully settled reading of the purchase terms. Before paying, request an order-specific explanation of those points, the exact medication and pharmacy, follow-up arrangements and the cancellation boundary for the relevant order type. The seven-day membership trial should not be confused with free medication, and cancellation should not be confused with a refund for an already-final order. Clear written answers would improve the transparency of the decision; they would not independently establish clinical effectiveness, verify credentials or replace a clinician’s assessment of individual treatment options.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- Third Avenue — pages/contact ↗
- Third Avenue — products/semaglutide ↗
- Third Avenue — policies/refund policy ↗
- Third Avenue — official website ↗
- Third Avenue — policies/privacy policy ↗
- Third Avenue — products/tirzepatide ↗
- Third Avenue — pages/glp 1 program ↗
- Third Avenue — glp 1 ↗
- Third Avenue — policies/terms of service ↗